Results 161 to 170 of about 21,331 (238)

Beyond relapses: How BTK inhibitors are shaping the future of progressive MS treatment. [PDF]

Neurotherapeutics
Naydovich LR, Orthmann-Murphy JL, Markowitz CE.   +2 more
europepmc   +1 more source

Novel BTK Inhibitors for Treating Autoimmune Disorders and Cancer. [PDF]

ACS Med Chem Lett, 2022
Sabnis RW.
europepmc   +1 more source

Optimal use of BTK inhibitors in Waldenström's macroglobulinemia: combination or single drug approach? [PDF]

Ther Adv Hematol
Solia E, Kastritis E.
europepmc   +1 more source

Efficacy and Safety of Syk and BTK Inhibitors in Immune Thrombocytopenia: A Comprehensive Review of Emerging Evidence. [PDF]

Mediators Inflamm
Heidari A, Mazid AS, Behroozfar M, Ghotbi N, Fathabadi F, Eghbali S, Heidari N.   +6 more
europepmc   +1 more source

BTK inhibitors potently impair platelet aggregation as a class effect independent of BTK specificity or dose in CLL and MCL. [PDF]

J Clin Exp Hematop
Kojima K, Watanabe S, Takeuchi A, Kunisawa N, Yoshida S.   +4 more
europepmc   +1 more source

High rate of complete responses induced by platinum-based regimen with BTK inhibitors in Richter syndrome. [PDF]

Blood Adv
Pongas G, Alasfour M, Cassidy DP, Alderuccio JP, Rosenblatt JD, Lossos IS.   +5 more
europepmc   +1 more source

The role of Janus kinase signaling in graft-versus-host disease and graft versus leukemia [PDF]

, 2018
Choi, Jaebok, DiPersio, John F, Schroeder, Mark A, Staser, Karl   +3 more
core   +2 more sources

Multiplex digital PCR enables sensitive detection of resistance to BTK inhibitors. [PDF]

Ann Hematol
Garcia M, Croizier C, Lazarian G, Quinquenel A, Tassin T, Bourgne C, Tournilhac O, Bay JO, Berger MG, Tchirkov A, Véronèse L, Guièze R.   +11 more
europepmc   +1 more source

Sustained remission with PD-1 and BTK inhibitors maintenance after chimeric antigen receptor T-cell therapy in CNS lymphoma. [PDF]

Cancer Immunol Immunother
Yu L, Ping N, Zou R, Zhu Q, Li J, Zhang X, Xia F, He J, Tu J, Kong D, Wu D, Jin Z, Qu C.   +12 more
europepmc   +1 more source

FDA-approved small-molecule kinase inhibitors [PDF]

, 2015
Clausen, Mads Hartvig, Nielsen, Thomas E., Wu, Peng   +2 more
core   +1 more source